Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico
Abstract
Authors
M Heibeck KY Westerhout V Naciben R Gasca-Pineda A Hernandez-Garduno C Chacon-Ramos